US clinical-stage biotech Qlaris Bio has announced positive top-line results from two U.S. Phase II clinical trials ...

Kura Oncology and Japan’s Kyowa Kirin have announced that their menin inhibitor ziftomenib met the primary endpoint in a ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from ...

Kane Biotech says it may have to move its manufacturing ... Radio-Canada is reporting Ottawa is preparing a multibillion-dollar aid package for citizens and businesses if Trump carries on with ...

The United States Postal Service announced on Tuesday it will temporarily suspend international package acceptance of inbound ...

Takeda has axed plans to seek approval for its failed epilepsy drug candidate soticlestat. The Japanese drugmaker pulled the ...

A Winnipeg-based biotechnology company says it's open to any financial help it can get from Ottawa as the U.S. continues to ...

Safely publish packages, store your packages alongside your code, and share your packages privately with your team.

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...